Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.09% Nasdaq Down0.73%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
14.05 Down 0.61(4.16%) 2:10PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 6,869   5,707   6,934   4,623  
Cost of Revenue -   -   -   -  
Gross Profit 6,869   5,707   6,934   4,623  
Operating Expenses
Research Development10,778  8,703  9,278  8,220  
Selling General and Administrative4,265  3,163  3,124  3,308  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,174) (6,159) (5,468) (6,905)
Income from Continuing Operations
Total Other Income/Expenses Net30  14  18  20  
Earnings Before Interest And Taxes(8,144)(6,145)(5,450)(6,885)
Interest Expense -   -   -   -  
Income Before Tax(8,144)(6,145)(5,450)(6,885)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,144)(6,145)(5,450)(6,885)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,144) (6,145) (5,450) (6,885)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,144) (6,145) (5,450) (6,885)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.